Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion

Ellen Shapiro, Marc E. Lippman

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Quantitative and qualitative changes in estrogen receptor follow addition of estradiol to estrogen responsive MCF-7 human breast cancer cells. We asked whether similar changes would accompany treatment of these cells with physiologically relevant concentrations of androgens. Androgen receptor sites were quantified by competitive protein binding assays on whole cells or extracts at various times following hormone addition. Both direct and exchange assays were employed. The androgen receptor in all of these experiments remained in a form which is completely exchangeable and approx 85% salt extractable. Quantity of receptor was unchanged (30,000 sites/cell, Kd 0.1 nM). Responsiveness to hormone treatment was demonstrated by antagonizing the estrogen dependent augmentation of cytoplasmic progesterone receptor in the MCF-7 cells with androgens. Thus, the androgen receptor was shown to be biologically active, but no time dependent quantitative or qualititative changes were observed during the first 6 h following androgen treatment.

Original languageEnglish (US)
Pages (from-to)15-20
Number of pages6
JournalJournal of Steroid Biochemistry
Volume22
Issue number1
DOIs
StatePublished - Jan 1985

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Fingerprint Dive into the research topics of 'Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion'. Together they form a unique fingerprint.

  • Cite this